BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  OMNIlife science Announces First Clinical Evaluations of Revolutionary OMNIBotics Active Spacer Robotic Tissue Balancing Device for Robotic-Assisted Total Knee Replacement

  OMNIlife science announced today that they have begun clinical evaluations of their exclusive OMNIBotics Active Spacer robotic tissue balancing device at three U.S. sites.

  October 31, 2017

   · 

  4 min read
• Pharm Country

  Octapharma USA Grant Supports Mission of First Hemophiliac to Climb the Seven Summits of the World

  Octapharma USA has provided a grant to support the final leg of the inspirational journey of Chris Bombardier, who hopes to become the first person with severe Hemophilia to climb the Seven Summits of the world.

  October 31, 2017

   · 

  3 min read
• BioMidwest

  Sermonix Pharmaceuticals Announces Recent Closure of $4.2 Million Seed Preferred Equity Bridge to Fund Operations, Prepare for Phase II Breast Cancer Study

  Sermonix announced its recent completion of a $4.2 million Seed Preferred Equity Bridge financing round to fund ongoing operations and prepare for entry of investigational drug lasofoxifene into a Phase II clinical trial.

  October 31, 2017

   · 

  4 min read
• Business

  Oncobiologics Announces Closing of Strategic Partnership Deal With GMS Tenshi Holdings

  The deal builds a strategic partnership to accelerate the commercialization of Oncobiologics’ biosimilar candidates.

  October 31, 2017

   · 

  5 min read
• Biotech Bay

  CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  Eight new employees were awarded grants of options to purchase CareDx common stock under NASDAQ Listing Rule 5635(c)(4).

  October 31, 2017

   · 

  1 min read
• Genetown

  VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares

  VBI also closed its concurrent registered direct offering of 7,475,410 common shares at a price of US$3.05 per share.

  October 31, 2017

   · 

  5 min read
• Business

  Aclaris Therapeutics to Announce Third Quarter 2017 Financial Results on November 7, 2017

  Management will conduct a conference call at 8:00 AM ET that day to discuss the Company’s financial results and provide a general business update.

  October 31, 2017

   · 

  1 min read
• Business

  Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on Tuesday, November 7, 2017

  t 8:30 a.m. ET that day, Selecta will host a conference call to discuss these results and provide a corporate update.

  October 31, 2017

   · 

  3 min read
• Drug Development

  Akcea and Ionis Report Positive Phase I/IIa Data With AKCEA-APOCIII-LRx

  Akcea expects to initiate Phase 2b in patients with hypertriglyceridemia with established cardiovascular disease by the end of this year.

  October 31, 2017

   · 

  6 min read
• Business

  Recro Pharma Reports Inducement Grants for New Staff - Oct. 31, 2017

  The company announced the expansion of its team through the employment of eight new employees in the areas of sales and marketing.

  October 31, 2017

   · 

  4 min read